(Q36933519)

17 August 2017

Subcutaneous apomorphine in the treatment of Parkinson's disease (English)

1 reference

17 August 2017

1 reference

1 reference

2

Lees AJ

1 reference

17 August 2017

Frankel JP

1

1 reference

17 August 2017

Kempster PA

series ordinal

3

1 reference

17 August 2017

Stern GM

series ordinal

4

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 February 1990

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

17 August 2017

1 reference

17 August 2017

53

1 reference

17 August 2017

96-101

1 reference

17 August 2017

2

1 reference

Cortical auditory disorders: clinical and psychoacoustic features

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=487943

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=487943

Therapeutic efficacy of apomorphine combined with an extracerebral inhibitor of dopamine receptors in Parkinson's disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=487943

Bromocriptine associated with a peripheral dopamine blocking agent in treatment of Parkinson's disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=487943

Deprenyl in Parkinson's disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=487943

Implications of combined treatment with 'Madopar' and L-deprenil in Parkinson's disease. A long-term study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=487943

Comparison of effects of L-dopa, amphetamine and apomorphine on firing rate of rat dopaminergic neurones.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=487943

Low dosages of bromocriptine added to levodopa in Parkinson's disease.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=487943

Role of subcutaneous apomorphine in parkinsonian voiding dysfunction

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=487943

Anal sphincter dysfunction in Parkinson's disease

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=487943

Subcutaneous apomorphine in Parkinson's disease

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=487943

On-off fluctuations in Parkinson's disease. A clinical and neuropharmacological study.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=487943

Injected apomorphine and orally administered levodopa in Parkinsonism

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=487943

Autoimmune hemolytic anemia due to levodopa therapy

4 September 2018

1 reference

12 December 2020

The use of dopamine agonists in the treatment of schizophrenia

1 reference

12 December 2020

Clinical and biochemical studies with controlled-release levodopa/carbidopa

1 reference

12 December 2020

SUBCUTANEOUS APOMORPHINE IN PARKINSONIAN ON-OFF OSCILLATIONS

1 reference

12 December 2020

Subcutaneous apomorphine in Parkinson's disease

1 reference

12 December 2020

Madopar HBS in fluctuating parkinsonian patients: two-year treatment

1 reference

12 December 2020

Subcutaneous apomorphine for on-off oscillations in Parkinson's disease

1 reference

12 December 2020

Off-period belching due to a reversible disturbance of oesophageal motility in Parkinson's disease and its treatment with apomorphine

1 reference

12 December 2020

Identifiers

DOI

10.1136/JNNP.53.2.96

1 reference

17 August 2017

1 reference

17 August 2017

1 reference